At 1.6 billion doses, India No. 1 in deals for Covid vaccine: Study

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.

See first dose of Johnson & Johnson Covid-19 vaccine being administered

The one-dose Johnson & Johnson Covid-19 vaccine is administered in the United States for the first time outside of a clinical trial at a mass vaccination site in Columbus, Ohio.

12-year-old vaccine trial participant shares his experience

Duke University is testing Pfizer’s coronavirus vaccine on 2,000 children between the ages of 12 and 15 years old. CNN’s Pamela Brown speaks with trial participant Caleb Chung and his father Dr. Richard Chung about the 12-year-old’s experience.

Study finds exercising could combat chronic inflammation

Exercising regularly has a number of health benefits, but did you know that exercising muscle could combat chronic inflammation on its own? According to a recent study led by Biomedical engineers at Duke University, the human muscle has an innate ability to ward off the damaging effects of chronic inflammation when exercised. The results of the study appeared on January 22 in the journal 'Science Advances'. The discovery was made possible through the use of lab-grown, engineered human muscle, demonstrating the potential power of the first-of-its-kind platform in such research endeavours. Inflammation is not inherently good or bad. When the body is injured, an initial low-level inflammation response clears away debris and helps tissue rebuild. Other times, the immune system overreacts and creates an inflammatory response that causes damage, like the often deadly cytokine storms brought on by some cases of COVID-19. And then, there are diseases that lead to chronic inflammation, such as rheumatoid arthritis and sarcopenia, which can cause the muscle to waste away and weaken its ability to contract. Among many molecules that can cause inflammation, one pro-inflammatory molecule, in particular, interferon-gamma, has been associated with various types of muscle wasting and dysfunction.

EU vaccine passports might not be ready by the summer. Here’s why

Concerns on fundamental rights, discrimination, data privacy, and forgery are poised to become stumbling blocks for the cross-border pass.

Coronavirus pandemic: Austria, Denmark look beyond EU to Israel for future vaccine

Austria and Denmark team up with Israel for next generation COVID-19 vaccines

The initiative comes amid growing frustration over delays in the EU's vaccine rollout.